One of the grimmest legacies of the war in the Pacific is still being fought 70 years on.
A victory over dengue, the intensely painful breakbone fever that conflict helped spread around the world, may be in sight. The US Army, which like its Japanese enemy lost thousands of men to the mosquito-borne disease in the 1940s, has piled resources into defeating the tropical killer.But it may be about to see the battle to develop the first vaccine won not in the United States but by French drug company Sanofi.